Matt Schumann

Matt Schumann has worked in various roles in the finance and accounting field since 2010. Matt began as Manager - Corporate Accounting at Horizon Pharma in 2010, then moved to SMS Assist, L.L.C. in 2016 as Director of Finance. In 2018, they became Chief Financial Officer at McCaulley Dowell LLP, and in 2020 they transitioned to Director of Finance & Accounting at Clarus Therapeutics. Currently, they are VP, Corporate Controller at Aerami Therapeutics.

Matt Schumann attended Saint Viator High School from 1996 to 2000. Matt then attended Bradley University from 2000 to 2003, studying Accounting & Finance. After that, they attended DePaul University from 2003 to 2005, where they earned a B.S. in Accounting.